Enhabit Inc. (NYSE: EHAB) is projecting strong hospice growth in the next year fueled in part by investments in technology and workforce development. The company is currently awaiting for the proverbial dust to settle following its victory in a recent lawsuit and the forthcoming new presidential administration. Enhabit anticipates a “nice bump” in patient census […]
Enhabit Inc. (NYSE: EHAB) expects consistent hospice growth even as it contends with payer and reimbursement headwinds for its home health business. The home health and hospice provider recently terminated its home health contract with the Medicare Advantage payer UnitedHealthcare, a subsidiary of UnitedHealth Group (NYSE: UNH), citing nine months of unsuccessful negotiations. In addition, […]
Enhabit Inc. (NYSE: EHB) has seen mixed financial results with headwinds impacting its overall revenue amid hospice tailwinds propelling these services toward sustainable growth. The home health and hospice provider formed when the company spun off from Encompass in 2022. The last year has been filled with various challenges alongside significant opportunities, said Enhabit President […]
The nation’s publicly traded hospice companies are primed for more acquisitions after a 2023 slump, fueled by census and growth. Transaction volume declined in the hospice and home-based care space in 2023, following the two record-breaking prior years. Many expect a rebound in 2024, and stirrings in the public company space signal that may come […]
Dallas-headquartered Enhabit Inc. (NYSE: EHAB) has provided a wider view into its decision to remain a standalone business. On Thursday, the company filed a preliminary proxy statement with the U.S. Securities and Exchange Commission (SEC), part of completing its recent strategic review process. The statement detailed the company’s recent decision not to pursue a sale, […]
Hospice will remain a core piece of Enhabit Inc.’s (NYSE: EHAB) strategic growth plans following its recent announcements to remain a standalone business. The company was mum about its strategic decision not to sell in Thursday’s earnings call, but executives elaborated on its home health and hospice focal points. Dallas-headquartered Enhabit has been mulling a […]
In case you missed it, Hospice News has launched a new specialty publication for palliative care professionals. You can subscribe to Palliative Care News here: Subscribe today! Enhabit Inc. (NYSE: EHAB) is in talks with interested parties about a possible forthcoming sale. Cost reductions helped propel revenue growth for Enhabit Inc.’s hospice business, though the […]
In case you missed it, Hospice News has launched a new specialty publication for palliative care professionals. You can subscribe to Palliative Care News here: Subscribe today! As hospices zero in on their investments in staff engagement and operational efficiencies, organizational culture is becoming a higher priority. Hospices nationwide are taking varied approaches around how they fuel […]
Investment trends in the hospice industry have meandered in recent years, impacting providers’ approaches to growth in 2024. The mix of hospice buyers has become more diverse during the past five years to include more private equity investors, large health and hospital systems and home health companies, along with payers. These trends will have lasting […]
Enhabit Inc. (NYSE: EHAB) is continuing to mull over a potential sale, with executives providing few details as the company determines its next steps. The Dallas-based home health and hospice company has been digging into a strategic review process since August that could result in a possible sale or merger of some or all of […]
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
